文献速递老年精神会诊联络精神医学

START心理干预对痴呆家庭照护者6年随访的临床效果及照护成本影响

Clinical effectiveness of the START (STrAtegies for RelaTives) psychological intervention for family carers and the effects on the cost of care for people with dementia: 6-year follow-up of a randomised controlled trial.
PubMed 文献 · Br J Psychiatry · 2020-01-01

本研究为随机对照优效试验的6年随访,纳入260名痴呆患者的家庭照护者,按2:1随机分配至START干预组或常规治疗组。结果显示START组在72个月时HADS-T评分改善优于常规治疗组(调整均差-2.00分,95%CI -3.38至-0.63),患者与照护者相关成本及入住养老院时间无显著组间差异,结论认为START临床有效且效果持续6年不增加成本。

要点

  • START干预可改善痴呆家庭照护者的焦虑抑郁症状,效果持续至6年随访。
  • 6年随访中干预组与常规治疗组在患者及照护者相关成本上无显著差异。
  • 两组入住养老院时间无显著差异(强度比0.88,95%CI 0.58-1.35)。

核心结论

  • START心理干预对痴呆家庭照护者具有临床效果,且效果持续6年而不增加成本。

研究设计与样本

  • 随机、平行组、优效性试验,2009年11月4日至2011年6月8日招募,随访6年。
  • 共260名自认的痴呆患者家庭照护者,按2:1随机分配至START组或常规治疗组。
  • START为8次手册化应对干预,由受督导的心理学毕业生实施。

主要发现

  • 72个月时干预组HADS-T评分较常规治疗组改善(调整均差-2.00分,95%CI -3.38至-0.63)。
  • 最后一年照护者相关成本中位数START组£377 vs 常规组£274,无显著差异。
  • 入住养老院时间组间无显著差异(强度比START:TAU为0.88,95%CI 0.58-1.35)。

临床怎么用

  • 可考虑将START手册化应对干预用于痴呆家庭照护者以改善其长期焦虑抑郁症状。

局限性

  • 6年临床疗效分析纳入START组173名中的222名(85.4%)及常规组87名,存在随访丢失。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The START (STrAtegies for RelaTives) intervention reduced depressive and anxiety symptoms of family carers of relatives with dementia at home over 2 years and was cost-effective. AIMS: To assess the clinical effectiveness over 6 years and the impact on costs and care home admission. METHOD: We conducted a randomised, parallel group, superiority trial recruiting from 4 November 2009 to 8 June 2011 with 6-year follow-up (trial registration: ISCTRN 70017938). A total of 260 self-identified family carers of people with dementia were randomised 2:1 to START, an eight-session manual-based coping intervention delivered by supervised psychology graduates, or to treatment as usual (TAU). The primary outcome was affective symptoms (Hospital Anxiety and Depression Scale, total score (HADS-T)). Secondary outcomes included patient and carer service costs and care home admission. RESULTS: In total, 222 (85.4%) of 173 carers randomised to START and 87 to TAU were included in the 6-year clinical efficacy analysis. Over 72 months, compared with TAU, the intervention group had improved scores on HADS-T (adjusted mean difference -2.00 points, 95% CI -3.38 to -0.63). Patient-related costs (START versus TAU, respectively: median £5759 v. £16 964 in the final year; P = 0.07) and carer-related costs (median £377 v. £274 in the final year) were not significantly different between groups nor were group differences in time until care home (intensity ratio START:TAU was 0.88, 95% CI 0.58-1.35). CONCLUSIONS: START is clinically effective and this effect lasts for 6 years without increasing costs. This is the first intervention with such a long-term clinical and possible economic benefit and has potential to make a difference to individual carers. DECLARATIONS OF INTEREST: G.L., Z.W. and C.C. are supported by the UCLH National Institute for Health Research (NIHR) Biomedical Research Centre. G.L. and P.R. were in part supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Z.W. reports during the conduct of the study; personal fees from GE Healthcare, grants from GE Healthcare, grants from Lundbeck, other from GE Healthcare, outside the submitted work.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Livingston G, Manela M, O'Keeffe A, et al. Clinical effectiveness of the START (STrAtegies for RelaTives) psychological intervention for family carers and the effects on the cost of care for people with dementia: 6-year follow-up of a randomised controlled trial. Br J Psychiatry. 2020. PMID: 31298169. doi:10.1192/bjp.2019.160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。